MA50669A - Nouveaux sels - Google Patents

Nouveaux sels

Info

Publication number
MA50669A
MA50669A MA050669A MA50669A MA50669A MA 50669 A MA50669 A MA 50669A MA 050669 A MA050669 A MA 050669A MA 50669 A MA50669 A MA 50669A MA 50669 A MA50669 A MA 50669A
Authority
MA
Morocco
Prior art keywords
new salts
salts
new
Prior art date
Application number
MA050669A
Other languages
English (en)
French (fr)
Inventor
Gerard M P Giblin
David T Macpherson
Julian Northen
Kalyan Vasudevan
Michael Williams
David R Witty
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of MA50669A publication Critical patent/MA50669A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA050669A 2017-09-28 2018-09-28 Nouveaux sels MA50669A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762564744P 2017-09-28 2017-09-28

Publications (1)

Publication Number Publication Date
MA50669A true MA50669A (fr) 2020-08-05

Family

ID=65902742

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050669A MA50669A (fr) 2017-09-28 2018-09-28 Nouveaux sels

Country Status (14)

Country Link
US (1) US20200255438A1 (enExample)
EP (1) EP3687533A4 (enExample)
JP (1) JP2020536070A (enExample)
KR (1) KR20200060404A (enExample)
CN (1) CN111343978A (enExample)
AU (2) AU2018338884A1 (enExample)
BR (1) BR112020005992A2 (enExample)
CA (1) CA3074923A1 (enExample)
EA (1) EA202090853A1 (enExample)
IL (1) IL273520A (enExample)
MA (1) MA50669A (enExample)
MX (1) MX2020003741A (enExample)
SG (1) SG11202002200UA (enExample)
WO (1) WO2019067961A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3077088A1 (en) 2017-10-10 2019-04-18 Biogen Inc. Process for preparing spiro derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2789711C (en) * 2010-02-17 2014-08-05 Amgen Inc. Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
EA201491990A1 (ru) * 2012-05-03 2015-02-27 Новартис Аг L-малатная соль 2,7-диазаспиро[4.5]дец-7-иловых производных и их кристаллические формы в качестве агонистов грелиновых рецепторов
GB201209015D0 (en) * 2012-05-22 2012-07-04 Convergence Pharmaceuticals Novel compounds

Also Published As

Publication number Publication date
AU2023202293A1 (en) 2023-05-11
EP3687533A4 (en) 2021-01-20
JP2020536070A (ja) 2020-12-10
AU2018338884A1 (en) 2020-04-16
IL273520A (en) 2020-05-31
KR20200060404A (ko) 2020-05-29
SG11202002200UA (en) 2020-04-29
MX2020003741A (es) 2021-01-08
CA3074923A1 (en) 2019-04-04
BR112020005992A2 (pt) 2020-09-29
US20200255438A1 (en) 2020-08-13
EA202090853A1 (ru) 2020-08-27
CN111343978A (zh) 2020-06-26
WO2019067961A1 (en) 2019-04-04
EP3687533A1 (en) 2020-08-05

Similar Documents

Publication Publication Date Title
FIC20220011I1 (fi) Lumasiraani tai sen suola
FIC20240005I1 (fi) Elasestrantti tai sen suola
EP3436455A4 (en) NOVEL SALTS AND CRYSTALS
HUE066592T2 (hu) Bilincs
DK3405050T3 (da) Børnesikret snusbeholder
MA50223A (fr) Sels inhibiteurs de ferroportine
MA44474A (fr) Nouveaux inhibiteurs de la ferroportine
LT3303334T (lt) Tirozinkinazės inhibitoriai
DK3442972T3 (da) Bromdomænehæmmere
EP3365371C0 (en) GITR AGONISTS
SI3512642T1 (sl) Rešitev brez kladiva
EP3687535A4 (en) NOVEL SALT AND CRYSTALS
DK3335532T3 (da) Tandharve
DK3402792T3 (da) Quinolin-2-on-derivater
DK3342949T3 (da) Tagstruktur
EP3383883A4 (en) SALTS OF CONJUGATES TO CANCER THERAPY
MA46280A (fr) Inhibiteurs de la dopamine-b-hydroxylase
EP3425626A4 (en) REED
EP3489155A4 (en) ATTACHED
DE112017000734A5 (de) Glycolsensor
DE112017006386A5 (de) Schraubarbeitszylinder
DK3323708T3 (da) Bovfender
DK3481826T3 (da) Tyrosinkinaseinhibitorer
DK3317248T3 (da) Sacubitrilcalciumsalte
EP3347550A4 (en) MAST FOR SUPPORTING A CABLE AND METHOD FOR PRODUCING THE MASTER